PATENT CLAIM ANALYSIS

Application Number: 16307450
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["530", "322000"]

Abstract:
The invention provides Dsg2-derived peptides for inhibiting EMT and/or vasculogenic mimicry and treating and/or preventing angiogenesis-related diseases. Also provided are pharmaceutical compositions comprising the peptide of the invention and methods of using the peptide of the invention in inhibiting EMT and/or vasculogenic mimicry, and treating and/or preventing angiogenesis-related diseases.

Claim (Index 19):
A synthetic peptide comprising an amino acid sequence selected from the group consisting of the following: SEQ2 IEPVQTICHDAEYVN; (SEQ\u2003ID\u2003NO:\u2003126)   SEQ3 AEYVNVTAEDLDGHP; (SEQ\u2003ID\u2003NO:\u2003127)   SEQ4 LDGHPNSGPFSFSVI; (SEQ\u2003ID\u2003NO:\u2003128)   SEQ5 SFSVIDKPPGMAEKW; (SEQ\u2003ID\u2003NO:\u2003129)   SEQ6 MAEKWKIARQESTSV; (SEQ\u2003ID\u2003NO:\u2003130)   SEQ7 ESTSVLLQQSEKKLG; (SEQ\u2003ID\u2003NO:\u2003131)   SEQ8 EKKLGRSEIQFLISD; (SEQ\u2003ID\u2003NO:\u2003132)   SEQ9 FLISDNQGFSCPEKQ; (SEQ\u2003ID\u2003NO:\u2003133)   SEQ10 CPEKQVLTLTVCECL; (SEQ\u2003ID\u2003NO:\u2003134) and   SEQ11 VCECLHGSGCREAQH. (SEQ\u2003ID\u2003NO:\u2003135)

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.73333
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13992998', '14896521', '15395648', '14745562', '13516511']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6330534583831218
- 35 USC 102 Novelty (BERT): 0.5156848788839925
- Combined Prediction Score: 0.6213166004332089
- Mean Citation Score: 266.771986
- Max Citation Score: 268.7109
- Similarity Product: 172.84373468720912

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test